Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06733129

Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room

Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room: a 3-arm Randomized Trial

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
1,218 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The best hypnotic choice to optimize the balance between good intubation condition quality and hemodynamic stability during RSI performed in the operating theatre remained to be investigated. Therefore, a randomized study evaluating the efficacy of propofol, ketamine, and a combination of both is appropriate. So, we designed the HyPnotiKs randomized controlled study to investigate the efficacy of these hypnotic drugs in patients undergoing RSI in the operating theatre. The primary endpoint will be the successful tracheal intubation at the first attempt without major arterial hypotension event.

Conditions

Interventions

TypeNameDescription
DRUGdirect IV injectiondirect IV injection at dosage of 2 mg/kg (adjusted body weight if BMI \> 30) after completing pre-oxygenation
DRUGcombination of Ketamine and Propofolcombination of Ketamine and Propofol described above: consecutive direct IV injection of Ketamine 1 mg/kg and Propofol 1 mg/kg (adjusted body weight if BMI \> 30). Dilution are not necessary.

Timeline

Start date
2025-04-14
Primary completion
2027-04-14
Completion
2027-04-30
First posted
2024-12-13
Last updated
2025-12-02

Locations

20 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06733129. Inclusion in this directory is not an endorsement.